Trials / Unknown
UnknownNCT03506763
Effect of Pre-medication in Pain Measures on Office Hysteroscopy
Effect of Pre-medication in Pain Measures on Office Hysteroscopy - Randomized Clinical Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 231 (estimated)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Will be perform a RCT to compare pain measure on office hysteroscopy after pre-medication with oral analgesic. Patients will be alocate to oral sodic diclofenac, scopolamin or placebo. We will compare visual analog score of pain after the procedure. Patients: patients with indication of office hysteroscopy to evaluate uterine intracavitary abnormality. Interventions Group 1 (control) The patients will receive about 2 h prior to the procedure 2 placebo tablets. Group 2 (diclofenac + scopolamine) The patients will receive about 2 h prior to the procedure 1 tablet of diclofenac sodium 50 mg and 1 tablet of scopolamine 2 mg. Group 3 (diclofenac only). Patients will receive approximately 2 h prior to the procedure 1 tablet of diclofenac sodium 50 mg and 1 tablet of placebo.
Detailed description
Pain during and 30 minutes after a hysteroscopy will be measured through the visual analog pain scale of 10 centimeters, considering 0 (no pain) and 10 (unbearable pain or the greatest pain ever experienced). Acceptance of the procedure and assessed through the Likert 5-point scale: 1) totally disagree; 2) disagree; 3) I do not agree or disagree; 4) I agree and 5) I totally agree.There will also be a need for analgesia after the procedure, the time spent in the observation room and the onset of vagal symptoms such as dizziness, malaise, nausea, vomiting or syncope
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo Oral + Placebo Oral | Placebo Oral + Placebo Oral |
| DRUG | Diclofenac oral + Placebo Oral | Diclofenac oral + Placebo Oral |
| DRUG | Diclofenac oral + scopolamina oral | Diclofenac oral + scopolamina oral |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-12-31
- Completion
- 2019-06-30
- First posted
- 2018-04-24
- Last updated
- 2018-04-24
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03506763. Inclusion in this directory is not an endorsement.